Application | Comment | Organism |
---|---|---|
drug development | the enzyme is a potential selective target for chemotherapy and drug development against malaria | Homo sapiens |
drug development | the enzyme is a potential selective target for chemotherapy and drug development against malaria | Plasmodium falciparum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
(6aR,11aS)-11-[(4-methylphenyl)sulfonyl]-6,6a,11,11a-tetrahydro-5H-benzo[a]carbazole | binds selectively to PfTopoI | Homo sapiens | |
(6aR,11aS)-11-[(4-methylphenyl)sulfonyl]-6,6a,11,11a-tetrahydro-5H-benzo[a]carbazole | binds selectively to PfTopoI | Plasmodium falciparum | |
(7aR,12aS)-5-methylidene-12-[(4-methylphenyl)sulfonyl]-7,7a,12,12a-tetrahydrobenzo[6,7]chromeno[4,3-b]indol-13(5H)-one | - |
Homo sapiens | |
(7aR,12aS)-5-methylidene-12-[(4-methylphenyl)sulfonyl]-7,7a,12,12a-tetrahydrobenzo[6,7]chromeno[4,3-b]indol-13(5H)-one | - |
Plasmodium falciparum | |
(7aS,12aS)-10-methoxy-5-methylidene-5,7,7a,12a-tetrahydro-13H-[1]benzofuro[3,2-c]benzo[g]chromen-13-one | - |
Homo sapiens | |
(7aS,12aS)-10-methoxy-5-methylidene-5,7,7a,12a-tetrahydro-13H-[1]benzofuro[3,2-c]benzo[g]chromen-13-one | - |
Plasmodium falciparum | |
(7aS,12aS)-11-methoxy-5-methylidene-13-oxo-5,7a,12a,13-tetrahydro-7H-[1]benzofuro[3,2-c]benzo[g]chromene-9-carbaldehyde | - |
Homo sapiens | |
(7aS,12aS)-11-methoxy-5-methylidene-13-oxo-5,7a,12a,13-tetrahydro-7H-[1]benzofuro[3,2-c]benzo[g]chromene-9-carbaldehyde | - |
Plasmodium falciparum | |
(7aS,12aS)-5-methylidene-5,7,7a,12a-tetrahydro-13H-[1]benzofuro[3,2-c]benzo[g]chromen-13-one | - |
Homo sapiens | |
(7aS,12aS)-5-methylidene-5,7,7a,12a-tetrahydro-13H-[1]benzofuro[3,2-c]benzo[g]chromen-13-one | - |
Plasmodium falciparum | |
camptothecin | - |
Homo sapiens | |
camptothecin | - |
Plasmodium falciparum | |
methyl (7aS,12aS)-5-methylidene-13-oxo-5,7a,12a,13-tetrahydro-7H-[1]benzofuro[3,2-c]benzo[g]chromene-9-carboxylate | - |
Homo sapiens | |
methyl (7aS,12aS)-5-methylidene-13-oxo-5,7a,12a,13-tetrahydro-7H-[1]benzofuro[3,2-c]benzo[g]chromene-9-carboxylate | - |
Plasmodium falciparum | |
additional information | isolation of six synthetic isoflavonoid derivatives that dock in the binding site of inhibitors camptothecin and topotecan inside the enzyme, no inhibition by LQB223, docking and molecular dynamics simulations, overview | Homo sapiens | |
additional information | isolation of six synthetic isoflavonoid derivatives that dock in the binding site of inhibitors camptothecin and topotecan inside the enzyme, cytotoxicity in CQ-sensitive (3D7) or CQ-resistant (W2) parasites, overview | Plasmodium falciparum | |
topotecan | - |
Homo sapiens | |
topotecan | - |
Plasmodium falciparum |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Plasmodium falciparum | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
DNA topoisomerase I | - |
Homo sapiens |
DNA topoisomerase I | - |
Plasmodium falciparum |
HssTopoI | - |
Homo sapiens |
PfTopoI | - |
Plasmodium falciparum |
Topoisomerase I | - |
Homo sapiens |
Topoisomerase I | - |
Plasmodium falciparum |